Nuvalent Inc
NUVL
Equity
ISIN null / Valor 112589757
NASDAQ (2026-02-27)
USD 101.95-1.91%
Nuvalent Inc
UMushroom community rating:
About company
Nuvalent Inc. is a biotechnology company focused on developing targeted therapies for patients with cancer.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
36.1%1Y
233%3Y
%5Y
Performance
46.7%1Y
52.2%3Y
72.9%5Y
Volatility
6858 M
Market cap (USD)
668,676
Daily traded volume (Shares)
80.72 / 76.93
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
